JPS633848B2 - - Google Patents
Info
- Publication number
- JPS633848B2 JPS633848B2 JP53079081A JP7908178A JPS633848B2 JP S633848 B2 JPS633848 B2 JP S633848B2 JP 53079081 A JP53079081 A JP 53079081A JP 7908178 A JP7908178 A JP 7908178A JP S633848 B2 JPS633848 B2 JP S633848B2
- Authority
- JP
- Japan
- Prior art keywords
- enzyme preparation
- oil
- preparation according
- aqueous phase
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7908178A JPS557228A (en) | 1978-06-29 | 1978-06-29 | Enzyme preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7908178A JPS557228A (en) | 1978-06-29 | 1978-06-29 | Enzyme preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS557228A JPS557228A (en) | 1980-01-19 |
| JPS633848B2 true JPS633848B2 (enExample) | 1988-01-26 |
Family
ID=13679936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7908178A Granted JPS557228A (en) | 1978-06-29 | 1978-06-29 | Enzyme preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS557228A (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5643209A (en) * | 1979-09-14 | 1981-04-21 | Kowa Co | External drug of urokinase |
| US5447729A (en) * | 1994-04-07 | 1995-09-05 | Pharmavene, Inc. | Multilamellar drug delivery systems |
| JP2006199589A (ja) * | 2003-09-03 | 2006-08-03 | Ltt Bio-Pharma Co Ltd | 生理活性タンパク質またはペプチドを含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる外用剤 |
| ES2736256T3 (es) * | 2011-03-14 | 2019-12-27 | Drug Delivery Solutions Ltd | Composición oftálmica |
| JP2014221043A (ja) * | 2014-06-04 | 2014-11-27 | 学校法人神奈川大学 | W/o/w型エマルション、w/o/w型エマルション酵素保存液、及び酵素保存方法 |
-
1978
- 1978-06-29 JP JP7908178A patent/JPS557228A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS557228A (en) | 1980-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU629832B2 (en) | Improved emulsions of highly fluorinated organic compounds | |
| Wise et al. | The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebrospinal-fluid pressure | |
| EP0307087B1 (en) | Fluorocarbon emulsions for in vivo use | |
| US5620699A (en) | Method for delivering nonaqueous fluorinated drug delivery vehicle suspensions | |
| KR100777647B1 (ko) | 프로포폴의 수용성 주사용 분산액 | |
| RU2460516C2 (ru) | Офтальмические эмульсии масло-в-воде, содержащие простагландины | |
| JPH0822815B2 (ja) | 高度にフツ素化された有機化合物の安定乳濁液 | |
| JPH07503254A (ja) | 超音波検査法のための強化剤としての安定性微小泡懸濁液 | |
| TR201808752T4 (tr) | Semiflorlanmış alkanları içeren o/w emülsiyonları. | |
| JPS58222014A (ja) | プロスタグランジンe↓1脂肪乳剤 | |
| NZ228781A (en) | Ultrasonic contrast medium comprising microparticles of a fatty acid, and small gas bubbles | |
| JPS59216820A (ja) | プロスタグランジン脂肪乳剤 | |
| JPS62270521A (ja) | フルルビプロフエン眼投与製剤 | |
| US5445812A (en) | Angiographic adjuvant | |
| JPS63501563A (ja) | 腟内送達用製剤 | |
| JPS6348214A (ja) | 1−〔2−(2,4−ジクロロフエニル)−3−メチル−1−ペンテニル〕−1h−イミダゾ−ルを含有する水中油型脂肪乳剤 | |
| JPS633848B2 (enExample) | ||
| Dunham et al. | INTRAVENOUS ADMINISTRATION OF FAT FOR NUTRITIONAL PURPOSES: EXPERIMENTAL STUDY | |
| RU2162692C1 (ru) | Состав на основе эмульсии перфторорганических соединений для медико-биологических целей | |
| US20070219127A1 (en) | Cyclosporin a compositions | |
| JPS58162517A (ja) | 脂溶性ビタミン含有脂肪乳剤 | |
| AU2001280084B2 (en) | Amphotericin b structured emulsion | |
| JPS60166626A (ja) | 血管造影剤 | |
| JPH03287542A (ja) | 改良された安定性と徐放作用を有する標的化学療法用抗癌剤エマルジョン及びその製法 | |
| US2870019A (en) | Therapeutic composition |